Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention aGVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Not applicableStudy completedNCT06900842
What this trial is testing

Chronic Pain in Post-Mastectomy Patients; The Difference Between Pectoral Nerve (PECS I-II) and Erector Spinal Plane (ESP) Blocks

Who this might be right for
Breast Cancer SurgeryPostoperative Pain, AcutePostoperative Pain, Chronic+7 more
Hacettepe University 44
Post-approval studies (Phase 4)Study completedNCT01742130
What this trial is testing

Early Hydration in Acute Myocardial Infarction

Who this might be right for
Contrast Induced Acute Kidney Injury
Ospedale Misericordia e Dolce 300
Not applicableStudy completedNCT02734654
What this trial is testing

Limb RIPC in Patients Undergoing Lung Lobectomy. Study of Oxidative Lung Damage

Who this might be right for
Acute Lung Injury
Instituto de Salud Carlos III 53
Not applicableEnded earlyNCT03116165
What this trial is testing

Cognitive-Behavioural Therapy as a Preventive Treatment for Post Traumatic Stress Disorder

Who this might be right for
Post Traumatic Stress Disorder
Karolinska Institutet 352
Not applicableStudy completedNCT00080873
What this trial is testing

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Children's Oncology Group 195
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Not applicableUnknownNCT02881645
What this trial is testing

Prevention of Critical Incidents Related to the Nursing With Patients in Intensive Care Units

Who this might be right for
Acute Conditions in Intensive Care
Central Hospital, Nancy, France 59,400
Post-approval studies (Phase 4)Ended earlyNCT04346667
What this trial is testing

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds

Who this might be right for
SARS-CoV-2Coronavirus InfectionAsymptomatic Condition+1 more
Government of Punjab, Specialized Healthcare and Medical Education Department 125
Not applicableNot Yet RecruitingNCT07572695
What this trial is testing

Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid LeukemiaAML, Relapsed/Refractory
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04225013
What this trial is testing

Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy

Who this might be right for
Kidney InjuryContrast-induced Nephropathy
R. Laura Vicente Vicente 150
Not applicableActive Not RecruitingNCT06416813
What this trial is testing

Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques

Who this might be right for
Acute Coronary Syndrome
Yong He 140
Not applicableStudy completedNCT03351049
What this trial is testing

An RCT on Support Surfaces for Pressure Ulcer Prevention

Who this might be right for
Pressure InjuryPressure Ulcer
David Brienza 457
Large-scale testing (Phase 3)Enrolling By InvitationNCT05787418
What this trial is testing

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Who this might be right for
COVID-19
Huahui Health 1,200
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)WithdrawnNCT02177760
What this trial is testing

Sirolimus Prophylaxis for aGVHD in TME SCID

Who this might be right for
Severe Combined ImmunodeficiencyTransplacental Maternal EngraftmentStem Cell Transplant
University of California, San Francisco
Large-scale testing (Phase 3)Ended earlyNCT03805789
What this trial is testing

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Who this might be right for
Acute-graft-versus-host Disease
CSL Behring 222
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Testing effectiveness (Phase 2)Study completedNCT02869347
What this trial is testing

Recombinant Human C1 Esterase Inhibitor in the Prevention of Contrast-induced Nephropathy in High-risk Subjects

Who this might be right for
Acute Kidney Injury
University Hospital, Basel, Switzerland 80
Next Page